间歇性激素治疗在前列腺癌生化复发中值得考虑，因为可以减轻心血管事件并降低其他影响。
Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other Effects.
发表日期：2023 Jan 21
作者：
Daniel H Kwon, Rahul R Aggarwal
来源：
European Urology Focus
摘要：
雄激素削减疗法（ADT）与局限性前列腺癌治疗后生化复发男性的更好预后有关，但可能使患者更容易患上心血管疾病。在这种情况下，值得考虑间歇性ADT，通过密切监测前列腺特异性抗原来决定何时在治疗期间重新开始ADT。由Elsevier B.V.出版。
Androgen deprivation therapy (ADT) is associated with better outcomes for men with biochemical recurrence following treatment for localized prostate cancer but can predispose patients to a higher risk of cardiovascular events. Intermittent ADT is worth considering in this setting, with close monitoring of prostate-specific antigen to decide when to restart ADT after off-treatment periods.Published by Elsevier B.V.